立他司特是整合素淋巴细胞功能相关抗原-1(LFA-1)的拮抗剂; 抑制Jurkat T细胞附着于ICAM-1的IC50为2.98nM,FDA批准的药物用于干眼的症状和体征的综合征的治疗,称为干燥性角结膜炎,通过抑制炎性细胞结合减少炎症。它经常被用来与环孢素(ikervis或restasis)干眼症的治疗包括睑板腺功能障碍和炎症性干眼。

清空选项
82278-73-7 Boc-Phe(3-Br)-OH
BD1550782278-73-798%
¥37.001g常备现货
13196-11-7 Benzofuran-6-ol
BD5655813196-11-795%
¥420.00100mg常备现货
1194550-59-8 (S)-Benzyl 2-amino-3-(3-(methylsulfonyl)phenyl)propanoate hydrochloride
BD3177761194550-59-897%
¥4118.0025g常备现货
588703-29-1 Methyl benzofuran-6-carboxylate
BD239007588703-29-195%
¥58.00250mg常备现货
6272-26-0 6-Hydroxybenzofuran-3(2H)-one
BD60256272-26-098%
¥22.001g常备现货
10203-08-4 3,5-Dichlorobenzaldehyde
BD1729910203-08-498%
¥1796.00500g常备现货
77095-51-3 Benzofuran-6-carboxylic acid
BD11576277095-51-398%
¥29.00250mg常备现货
82311-69-1 (S)-2-Amino-3-(3-bromophenyl)propanoic acid
BD2007482311-69-198%
¥541.0025g常备现货
1025967-78-5 (S)-2-(2-(benzofuran-6-carbonyl)-5,7-dichloro-1,2,3,4-tetrahydroisoquinoline-6-carboxamido)-3-(3-(methylsulfonyl)phenyl)propanoic acid
BD7580931025967-78-597%
¥530.00250mg常备现货
89315-56-0 5,7-Dichloro-1,2,3,4-tetrahydroisoquinoline
BD26240989315-56-098%
¥1578.001g常备现货
227752-25-2 Benzofuran-6-yl trifluoromethanesulfonate
BD330974227752-25-295+%
¥2968.001g
299912-77-9 6-((tert-Butyldimethylsilyl)oxy)benzofuran-3(2H)-one
BD449415299912-77-997%
¥4419.005g
1194550-56-5 5,7-Dichloro-2-trityl-1,2,3,4-tetrahydroisoquinoline-6-carboxylic acid
BD6318221194550-56-598%
¥2939.001g
1289646-72-5 5,7-Dichloro-2-trityl-1,2,3,4-tetrahydroisoquinoline
BD009772201289646-72-597%
¥3255.001g
1289646-78-1 N-Boc-3-(methylsulfonyl)-L-phenylalanine Benzyl Ester
BD011093561289646-78-198%
¥4419.001g
1194550-65-6 Benzyl (S)-2-(5,7-dichloro-1,2,3,4-tetrahydroisoquinoline-6-carboxamido)-3-(3-(methylsulfonyl)phenyl)propanoate hydrochloride
BD011185931194550-65-698%
¥20454.001g
1289646-76-9 (S)-2-((tert-Butoxycarbonyl)amino)-3-(3-(methylsulfonyl)phenyl)propanoic acid
BD011389471289646-76-998%
¥14499.005g
1